Unravelling transmission of Mycobacterium avium subspecies paratuberculosis to dairy calves: results of a lifelong longitudinal study

INVITED REVIEW: An evaluation of EFSA opinion on calf welfare from a nutritional and management perspective

In March, 2023, the European Food Safety Authority published a Scientific Opinion on Calf Welfare. This Opinion was prepared in response to a request from the European Commission to provide an independent view on the welfare of calves that reflected the most recent scientific knowledge. Data sources used to develop their recommendations included peer-reviewed studies, expert knowledge, and gray literature. The Opinion considered specific scenarios and welfare consequences of specific management practices, including feeding fiber to calves raised for white veal and amount of cow-calf contact. Their Opinion suggested that calves should be fed specific quantities of forage NDF during the rearing cycle. Regarding separation of calves, the Committee recommended that the calf should remain with the cow for a minimum of 24 h and then be housed with another calf. They further suggested that prolonged cow-calf contact should increasingly be implemented due to benefits to both cow and calf to minimize stress of separation. The objective of this review is to assess the veracity of these recommendations and the scientific data that underpins them. This review will present a literature to support the contention that, from a nutritional and management perspective, these recommendations may impair calf welfare by exposing calves to innutritious rations containing excess fiber and increasing their risk of morbidity and mortality due to poor colostrum intake and exposure to disease-causing pathogens. Alternative recommendations are made that may further the goal of calf welfare in the context of nutrition and housing.

Dataset on risk factors for seroconversion against Mycobacterium avium subspecies paratuberculosis in dairy cows

Johne's disease (JD) is a chronic wasting disease caused by Mycobacterium avium subspecies paratuberculosis (MAP). MAP is responsible for large economic losses for the dairy sector and has been linked to human disease. Susceptibly to MAP is mainly limited to young animals and diagnostic tests are poor at detecting MAP in early stages of infection. Therefore, ascertaining the contribution of the dam to the risk of calf infection and the relative role of the different infection routes is important to inform disease control measures. This data article presents MAP exposures at time of calving on a cohort of 439 calves born between 2012 and 2013 from 6 UK dairy herds. Each calf participated in routine quarterly MAP milk ELISA testing using the IDEXX Porquire ELISA. Each animal was followed until testing MAP positive, being culled or end of follow up (January 2023). The dataset includes risk factors associated with transmission via colostrum route (MAP status of cow giving colostrum); transmission via the dam (MAP status of the dam) and transmission via fecal oral route (whether at birth the calf spent a long time in a dirty yard). Ascertainment of exposure to risk factors involved video recording and self-capture data forms from time of calving in the maternity area of the farms until calf left the area. The dataset provides a unique opportunity to examine MAP infection and its relationship with different exposures at time of birth, where cows were followed up during their entire lives.

Alginate-Encapsulated Mycobacteriophage: A Potential Approach for the Management of Intestinal Mycobacterial Disease

Encapsulated medication is a common method of administering therapeutic treatments. As researchers explore alternative therapies, it is likely that encapsulation will remain a feature of these novel treatments, particularly when routes of delivery are considered. For instance, alginate-encapsulation is often favoured where gastric digestion poses an obstacle. When exposed to cations (namely Ca2+), alginate readily forms gels that are resilient to acidic conditions and readily dissociate in response to mid-range pH. This action can be extremely valuable for the encapsulation of phages. The efficient delivery of phages to the intestine is important when considering mycobacteriophage (MP) therapy (or MP prophylaxis) for disseminated mycobacterial infections and chronic gastroenteritis conditions. This study presents the design and in vitro validation of an alginate-encapsulated MP capable of releasing phages in a pH-dependent manner. Ultimately, it is shown that encapsulated phages pretreated with simulated gastric fluid (SGF) are capable of releasing viable phages into simulated intestinal fluid (SIF) and thereby reducing the mycobacterial numbers in spiked SIF by 90%. These findings suggest that alginate encapsulation may be a viable option for therapeutic and prophylactic approaches to the management of intestinal mycobacterial disease, such as Johne's disease.